We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
-4.49%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$45B
AUM Growth
-$1.03B
Cap. Flow
+$1.39B
Cap. Flow %
3.09%
Top 10 Hldgs %
15.88%
Holding
3,457
New
194
Increased
1,567
Reduced
1,345
Closed
189

Sector Composition

Rank Sector Weight
1 Technology 10.69%
2 Financials 6.56%
3 Healthcare 6.47%
4 Consumer Discretionary 5.26%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGRY
3151
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$19K ﹤0.01%
11,300
GLMD icon
3152
Galmed Pharmaceuticals
GLMD
$4.47M
$18K ﹤0.01%
324
-33
-9% -$2.82K
RTX icon
3153
CALL
RTX Corp
RTX
$296B
$18K ﹤0.01%
+13,700
New +$1.24M
BBGI icon
3154
Beasley Broadcasting Group
BBGI
$38.2M
$17K ﹤0.01%
765
BHF icon
3155
CALL
Brighthouse Financial
BHF
$3.45B
$17K ﹤0.01%
14,000
INO icon
3156
Inovio Pharmaceuticals
INO
$94.9M
$17K ﹤0.01%
839
-51
-6% -$1.31K
CADE
3157
CALL
DELISTED
Cadence Bank
CADE
$15K ﹤0.01%
+30,000
New +$770K
URG
3158
Ur-Energy
URG
$533M
$15K ﹤0.01%
13,978
SVVC
3159
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$15K ﹤0.01%
11,000
SPRU icon
3160
Spruce Power Holding Corp
SPRU
$36M
$14K ﹤0.01%
1,980
-1,525
-44% -$14.5K
TONX
3161
TON Strategy Co
TONX
$153M
$14K ﹤0.01%
4
SDC
3162
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$14K ﹤0.01%
15,990
-5,000
-24% -$6.07K
ACB
3163
Aurora Cannabis
ACB
$240M
$13K ﹤0.01%
1,034
-91
-8% -$1.34K
CTXR icon
3164
Citius Pharmaceuticals
CTXR
$20.5M
$13K ﹤0.01%
+444
New +$12.2K
NGD
3165
DELISTED
New Gold Inc
NGD
$13K ﹤0.01%
15,239
AIXC
3166
AIxCrypto Holdings Inc
AIXC
$15M
$13K ﹤0.01%
97
STAB
3167
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$13K ﹤0.01%
102,250
-10,000
-9% -$2.11K
CRIS icon
3168
Curis
CRIS
$3.7M
$12K ﹤0.01%
42
+6
+17% +$2.42K
IMDX
3169
Insight Molecular Diagnostics
IMDX
$140M
$12K ﹤0.01%
839
VRM icon
3170
Vroom Inc
VRM
$53.7M
$12K ﹤0.01%
130
-54
-29% -$7.21K
HTT
3171
High Templar Tech Ltd
HTT
$390M
$11K ﹤0.01%
11,698
TLRY icon
3172
CALL
Tilray
TLRY
$648M
$11K ﹤0.01%
2,090
+1,030
+97% +$36.1K
VALE icon
3173
CALL
Vale
VALE
$59.1B
$11K ﹤0.01%
12,000
-500
-4% -$6.58K
VSTM icon
3174
Verastem
VSTM
$628M
$11K ﹤0.01%
1,061
WATT icon
3175
Energous
WATT
$94.8M
$11K ﹤0.01%
+18
New +$13K

Similar funds

Raymond James Financial Services Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James Financial Services Advisors held 3,457 positions worth $45B, down 2.2% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James Financial Services Advisors deployed $1.39B of net new capital in Q3 2022, opening 194 new positions and adding to 1,567 existing holdings. Its largest new stake was iShares iBonds Dec 2030 Term Corporate ETF: 455,624 shares worth $9.23M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Roper Technologies, an estimated $59M trimmed.

  • Raymond James Financial Services Advisors's largest Q3 2022 buy was iShares iBonds Dec 2030 Term Corporate ETF: 455,624 shares worth $9.23M.
  • Raymond James Financial Services Advisors added most to Vanguard S&P 500 ETF in Q3 2022, an estimated $108M increase.
  • Raymond James Financial Services Advisors's biggest Q3 2022 reduction was Roper Technologies, cutting an estimated $59M.
  • Raymond James Financial Services Advisors fully exited State Street SPDR Portfolio Long Term Corporate Bond ETF in Q3 2022, selling an estimated $17.5M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 16% of its $45B portfolio in Q3 2022.
  • Raymond James Financial Services Advisors opened 194 new positions and closed 189 in Q3 2022.
  • Raymond James Financial Services Advisors's portfolio value fell 2.2% quarter-over-quarter to $45B.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2022, filed 25 Oct 2022.